The overwhelming body of research on T regulatory cells (Tregs) has focused on CD4+CD25+Foxp3+ T cells. However, recent years have witnessed a resurgence in interest in CD4-CD8+, CD4-CD8- (double negative; DN), and CD4+Foxp3- Tr1 Tregs and their role in controlling autoimmune diseases and in promoting the survival of organ allografts and xenografts. CD8+ and DN Tregs can arise spontaneously (natural Tregs) or can be induced in situ. Both CD8+ and DN Tregs have been shown to enhance the survival of organ allografts and xenografts. Additionally, both can suppress alloimmune responses by contact-dependent mechanisms by either inducing apoptosis or mediating direct cytolysis of effector T cells. CD8+, DN, and Tr1 Tregs can also act in a contact-independent manner by elaborating soluble immunosuppressive factors such TGF-β and IL-10. Applying CD8+, DN, and Tr1 Tregs for enhancing the survival of organ allografts and xenografts is still in its infancy but holds significant potential. Furthermore, there is a need for a more comprehensive understanding of how current immunosuppressive therapies applied to organ transplantations affect the wide array of Treg populations.